(Q36957698)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17910085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

review article

1 reference

title

Alzheimer's disease in Down syndrome: neurobiology and risk (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17910085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

0 references

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17910085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

author name string

Ira T Lott

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17910085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17910085%20AND%20SRC:MED&resulttype=core&format=json

Mental Retardation and Developmental Disabilities Research Reviews

8 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17910085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17910085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17910085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

page(s)

237-246

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17910085%20AND%20SRC:MED&resulttype=core&format=json

Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies

8 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

Plasma levels of amyloid beta-protein 42 are increased in women with mild cognitive impairment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential effects of APOE genotype and presenilin mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

Alzheimer's Disease and Maternal Age

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

Serum cholesterol, APOE genotype, and the risk of Alzheimer's disease: a population-based study of African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

Association of decreased paternal age and late-onset Alzheimer's disease. An example of genetic imprinting?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

Temporal cortex hypermetabolism in Down syndrome prior to the onset of dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

Parallel Compensatory and Pathological Events Associated with Tau Pathology in Middle Aged Individuals with Down Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

Neuropathological changes in Down's syndrome hippocampal formation. Effect of age and apolipoprotein E genotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

Early senile dementia in mongoloid idiocy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

APOE genotype and gender effects on Alzheimer disease in 100 adults with Down syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

A prospective study of Alzheimer disease in Down syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

Cholesterol and neuropathologic markers of AD: a population-based autopsy study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

Low glucose metabolism during brain stimulation in older Down's syndrome subjects at risk for Alzheimer's disease prior to dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

Free radical damage in Down's syndrome brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

APOE genotype, plasma lipids, lipoproteins, and AD in community elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

Dementia in Down's syndrome: cerebral glucose utilization, neuropsychological assessment, and neuropathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

Regional cerebral glucose metabolism is normal in young adults with Down syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

Earlier onset of Alzheimer's disease in men with Down syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

Childhood mental ability and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMRDD.20163

21 January 2018

Identifiers

DOI

10.1002/MRDD.20163

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17910085%20AND%20SRC:MED&resulttype=core&format=json

8 January 2020

1 reference